These factors include, among others, the difficulty of predicting the timing and outcome of any appeal of the Kentucky drug pricing litigation or other pending drug pricing lawsuits, and risks that an adverse outcome in such litigation could render Watson liable for substantial damages; successful compliance with governmental regulations applicable to Watson and its third party manufacturers' faci